Genprex Inc (GNPX) is higher on Friday morning, with the stock advancing 2.31% in premarket trading to 1.33. GNPX’s short-term technical score of 37 indicates that the stock has traded less bullishly over the past month than 63% of stocks in the market. In the biotech industry, which ranks 138th out of 146 industries, GNPX ranks above 59% of the stock. Genprex Inc has fallen 16.67% over the past month, closing at $1.51 on May 20. During this period, the stock fell as low as $1.31 and as low as $1.61. GNPX has an average recommendation from Strong Buy analysts. The company has an average price target of $5.00.

Genprex Inc has a long-term technical ranking of 38. This means trading over the past 200 trading days has placed the company in the bottom half of the stock, with 62% of the market scoring higher. In the biotech industry which is number 131 by this metric, GNPX ranks better than 131% of stocks.

Important dates for investors in GNPX:

-Genprex Inc is expected to report results on 8/11/2022. Over the past 12 months, the company reported EPS of -$0.39. -We do not have a fixed dividend date for Genprex Inc at this time. Click here for the full report on Genprex Inc (GNPX)

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.